Related Experiment Videos
[Detection of differentially expressed genes in hepatocellular carcinoma using DNA microarray]
1State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, 200433 China.
Yi Chuan Xue Bao = Acta Genetica Sinica
|February 24, 2001
Summary
Researchers identified 903 genes with significant expression changes in hepatocellular carcinoma (HCC) using high-throughput microarray analysis. These genes show potential for diagnosing and treating liver cancer.
Area of Science:
- Genomics
- Molecular Biology
- Cancer Research
Context:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Understanding gene expression differences between normal and cancerous liver cells is crucial for developing targeted therapies.
- High-throughput microarray technology enables large-scale gene expression profiling.
Purpose:
- To identify differentially expressed genes between normal hepatocytes and hepatocellular carcinoma tissues.
- To discover potential molecular markers for HCC diagnosis and therapeutic targets.
Summary:
- High-throughput DNA microarrays, utilizing 4,096 human cDNAs, were employed to analyze gene expression profiles.
- Messenger RNA (mRNA) from normal and HCC tissues was labeled with fluorescent dyes (Cy3 and Cy5) and hybridized to the arrays.
- Analysis of four replicate experiments revealed 903 genes with an average expression ratio greater than 3.0 between cancerous and normal tissues.
Impact:
- Identified 903 candidate genes associated with hepatocellular carcinoma.
- These genes represent potential biomarkers for HCC diagnosis.
- The identified genes may offer novel therapeutic targets for liver cancer treatment.